Adiponectin profile and Irisin expression in Italian obese children: Association with insulin‐resistance

[1]  T. Funahashi,et al.  [Adiponectin]. , 2020, Nihon rinsho. Japanese journal of clinical medicine.

[2]  S. Wiegand,et al.  Leptin but not adiponectin is related to type 2 diabetes mellitus in obese adolescents , 2016, Pediatric diabetes.

[3]  B. Dallapiccola,et al.  Reference ranges of HOMA-IR in normal-weight and obese young Caucasians , 2016, Acta Diabetologica.

[4]  A. Jamurtas,et al.  Adiponectin, Resistin, and Visfatin in Childhood Obesity and Exercise. , 2015, Pediatric exercise science.

[5]  T. Hansen,et al.  Reference values for serum total adiponectin in healthy non-obese children and adolescents. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[6]  Chi-Jen Chang,et al.  Evidence in Obese Children: Contribution of Hyperlipidemia, Obesity-Inflammation, and Insulin Sensitivity , 2015, PloS one.

[7]  M. Goodarzi,et al.  Iranian Journal of Basic Medical Sciences Adiponectin: an Adipokine with Protective Features against Metabolic Syndrome , 2022 .

[8]  Paula Martins,et al.  Insulin Resistance, Dyslipidemia and Cardiovascular Changes in a Group of Obese Children , 2015, Arquivos brasileiros de cardiologia.

[9]  S. Kim,et al.  Irisin, a Novel Myokine, Regulates Glucose Uptake in Skeletal Muscle Cells via AMPK. , 2015, Molecular endocrinology.

[10]  R. Kelishadi,et al.  Systematic review on the association of abdominal obesity in children and adolescents with cardio-metabolic risk factors , 2015, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[11]  W. Dietz,et al.  Progress in the Control of Childhood Obesity , 2015, Pediatrics.

[12]  L. Pinelli,et al.  Adiponectin/resistin levels and insulin resistance in children: a four country comparison study , 2015, International Journal of Pediatric Endocrinology.

[13]  M. Redondo,et al.  Serum adiposity‐induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes , 2014, Pediatric diabetes.

[14]  C. Mantzoros,et al.  Exercise-induced irisin secretion is independent of age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation. , 2014, The Journal of clinical endocrinology and metabolism.

[15]  C. Mermier,et al.  Characterization of the metabolic effects of irisin on skeletal muscle in vitro , 2014, Diabetes, obesity & metabolism.

[16]  C. Costagliola,et al.  New Insight into Adiponectin Role in Obesity and Obesity-Related Diseases , 2014, BioMed research international.

[17]  A. Stengel,et al.  Irisin as a muscle-derived hormone stimulating thermogenesis – A critical update , 2014, Peptides.

[18]  J. Martínez,et al.  Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. , 2014, Metabolism: clinical and experimental.

[19]  G. Sesti,et al.  High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects , 2014, Acta Diabetologica.

[20]  J. Martínez,et al.  Longitudinal variation of circulating irisin after an energy restriction‐induced weight loss and following weight regain in obese men and women , 2014, American journal of human biology : the official journal of the Human Biology Council.

[21]  Mary T. Brinkoetter,et al.  Circulating irisin in relation to insulin resistance and the metabolic syndrome. , 2013, The Journal of clinical endocrinology and metabolism.

[22]  M. Capasso,et al.  Adiponectin oligomers as potential indicators of adipose tissue improvement in obese subjects. , 2013, European journal of endocrinology.

[23]  F. Casanueva,et al.  FNDC5/Irisin Is Not Only a Myokine but Also an Adipokine , 2013, PloS one.

[24]  O. Scudiero,et al.  Tissue-specific downregulation of the adiponectin "system": possible implications for fat accumulation tendency in the pig. , 2013, Domestic animal endocrinology.

[25]  J. Moreno-Navarrete,et al.  Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. , 2013, The Journal of clinical endocrinology and metabolism.

[26]  L. Perrone,et al.  Predicting Metabolic Syndrome in Obese Children and Adolescents: Look, Measure and Ask , 2013, Obesity Facts.

[27]  Mary T. Brinkoetter,et al.  FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. , 2012, Metabolism: clinical and experimental.

[28]  Peter K. Davidsen,et al.  Is irisin a human exercise gene? , 2012, Nature.

[29]  J. Teresi,et al.  Adiponectin and All-Cause Mortality in Elderly People With Type 2 Diabetes , 2012, Diabetes Care.

[30]  M. Masullo,et al.  Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease. , 2012, The international journal of biochemistry & cell biology.

[31]  C. Drevon,et al.  Secreted proteins from adipose tissue and skeletal muscle – adipokines, myokines and adipose/muscle cross-talk , 2011, Archives of physiology and biochemistry.

[32]  E. Petrucci,et al.  Adiponectin: an intriguing hormone for paediatricians , 2008, Acta paediatrica.

[33]  C. Nishida,et al.  Development of a WHO growth reference for school-aged children and adolescents. , 2007, Bulletin of the World Health Organization.

[34]  Hyon K. Choi,et al.  Serum Concentrations of Uric Acid and the Metabolic Syndrome Among US Children and Adolescents , 2007, Circulation.

[35]  N. Tajima,et al.  Childhood obesity and its relation to serum adiponectin and leptin: a report from a population-based study. , 2007, Diabetes research and clinical practice.

[36]  M. Raj,et al.  Obesity and cardiovascular risk in children and adolescents , 2012, Indian journal of endocrinology and metabolism.